
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and ... Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.105 | -7 | 1.5 | 1.67 | 1.3 | 5109064 | 1.50759688 | CS |
4 | 0.995 | 248.75 | 0.4 | 2.74 | 0.3546 | 41850558 | 1.34130611 | CS |
12 | 0.77 | 123.2 | 0.625 | 2.74 | 0.3546 | 15135851 | 1.28954704 | CS |
26 | 0.4244 | 43.7255305996 | 0.9706 | 2.74 | 0.3546 | 6772053 | 1.27368974 | CS |
52 | -2.605 | -65.125 | 4 | 4.74 | 0.3546 | 3681617 | 1.36568476 | CS |
156 | -3.305 | -70.3191489362 | 4.7 | 5.195 | 0.3546 | 1822670 | 1.64975846 | CS |
260 | -3.305 | -70.3191489362 | 4.7 | 5.195 | 0.3546 | 1822670 | 1.64975846 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관